Double diabetes-when type 1 diabetes meets type 2 diabetes: definition, pathogenesis and recognition

被引:43
作者
Bielka, Weronika [1 ]
Przezak, Agnieszka [1 ]
Moleda, Piotr [1 ]
Pius-Sadowska, Ewa [2 ]
Machalinski, Boguslaw [2 ]
机构
[1] Pomeranian Med Univ, Dept Diabetol & Internal Dis, PL-72010 Police, Poland
[2] Pomeranian Med Univ, Dept Gen Pathol, Szczecin, Poland
关键词
Diabetes; Type; 1; diabetes; 2; Double diabetes; Insulin resistance; Metabolic syndrome; Indirect insulin resistance markers; LIPID-ACCUMULATION PRODUCT; VISCERAL ADIPOSITY INDEX; GLUCOSE DISPOSAL RATE; PERIPHERAL INSULIN SENSITIVITY; LIPOPROTEIN-CHOLESTEROL RATIO; CARDIOVASCULAR-DISEASE RISK; TO-HEIGHT RATIO; METABOLIC SYNDROME; ACCELERATOR HYPOTHESIS; WEIGHT-GAIN;
D O I
10.1186/s12933-024-02145-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Currently, the differentiation between type 1 diabetes (T1D) and type 2 diabetes (T2D) is not straightforward, and the features of both types of diabetes coexist in one subject. This situation triggered the need to discriminate so-called double diabetes (DD), hybrid diabetes or type 1.5 diabetes, which is generally described as the presence of the insulin resistance characteristic of metabolic syndrome in individuals diagnosed with T1D. DD not only raises the question of proper classification of diabetes but is also associated with a significantly greater risk of developing micro- and macroangiopathic complications, which was independent of glycaemic control. When considering the global obesity pandemic and increasing incidence of T1D, the prevalence of DD may also presumably increase. Therefore, it is of the highest priority to discover the mechanisms underlying the development of DD and to identify appropriate methods to prevent or treat DD. In this article, we describe how the definition of double diabetes has changed over the years and how it is currently defined. We discuss the accuracy of including metabolic syndrome in the DD definition. We also present possible hypotheses connecting insulin resistance with T1D and propose possible methods to identify individuals with double diabetes based on indirect insulin resistance markers, which are easily assessed in everyday clinical practice. Moreover, we discuss adjuvant therapy which may be considered in double diabetic patients.
引用
收藏
页数:13
相关论文
共 136 条
[1]   Health Effects of Overweight and Obesity in 195 Countries over 25 Years [J].
Afshin, Ashkan ;
Forouzanfar, Mohammad H. ;
Reitsma, Marissa B. ;
Sur, Patrick ;
Estep, Kara ;
Lee, Alex ;
Marczak, Laurie ;
Mokdad, Ali H. ;
Moradi-Lakeh, Maziar ;
Naghavi, Mohsen ;
Salama, Joseph S. ;
Vos, Theo ;
Abate, Kalkidan H. ;
Abbafati, Cristiana ;
Ahmed, Muktar B. ;
Al-Aly, Ziyad ;
Alkerwi, Ala'a ;
Al-Raddadi, Rajaa ;
Amare, Azmeraw T. ;
Amberbir, Alemayehu ;
Amegah, Adeladza K. ;
Amini, Erfan ;
Amrock, Stephen M. ;
Anjana, Ranjit M. ;
Arnlov, Johan ;
Asayesh, Hamid ;
Banerjee, Amitava ;
Barac, Aleksandra ;
Baye, Estifanos ;
Bennett, Derrick A. ;
Beyene, Addisu S. ;
Biadgilign, Sibhatu ;
Biryukov, Stan ;
Bjertness, Espen ;
Boneya, Dube J. ;
Campos-Nonato, Ismael ;
Carrero, Juan J. ;
Cecilio, Pedro ;
Cercy, Kelly ;
Ciobanu, Liliana G. ;
Cornaby, Leslie ;
Damtew, Solomon A. ;
Dandona, Lalit ;
Dandona, Rakhi ;
Dharmaratne, Samath D. ;
Duncan, Bruce B. ;
Eshrati, Babak ;
Esteghamati, Alireza ;
Feigin, Valery L. ;
Fernandes, Joao C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (01) :13-27
[2]   Visceral adiposity index (VAI), lipid accumulation product (LAP), and product of triglycerides and glucose (TyG) to discriminate prediabetes and diabetes [J].
Ahn, Nayeon ;
Baumeister, Sebastian E. ;
Amann, Ute ;
Rathmann, Wolfgang ;
Peters, Annette ;
Huth, Cornelia ;
Thorand, Barbara ;
Meisinger, Christa .
SCIENTIFIC REPORTS, 2019, 9 (1)
[3]   Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial [J].
Ahren, Bo ;
Hirsch, Irl B. ;
Pieber, Thomas R. ;
Mathieu, Chantal ;
Gomez-Peralta, Fernando ;
Hansen, Troels Krarup ;
Philotheou, Areti ;
Birch, Sune ;
Christiansen, Erik ;
Jensen, Thomas Jon ;
Buse, John B. .
DIABETES CARE, 2016, 39 (10) :1693-1701
[4]   Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity [J].
Alberti, K. G. M. M. ;
Eckel, Robert H. ;
Grundy, Scott M. ;
Zimmet, Paul Z. ;
Cleeman, James I. ;
Donato, Karen A. ;
Fruchart, Jean-Charles ;
James, W. Philip T. ;
Loria, Catherine M. ;
Smith, Sidney C., Jr. .
CIRCULATION, 2009, 120 (16) :1640-1645
[5]   Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
DIABETIC MEDICINE, 2006, 23 (05) :469-480
[6]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[7]  
2-S
[8]   Indexes for insulin resistance assessment in Mexican individuals without diabetes [J].
Almeda-Valdes, Paloma ;
Bello-Chavolla, Omar Y. ;
Caballeros-Barragan, Cesar R. ;
Gomez-Velasco, Donaji V. ;
Viveros-Ruiz, Tania ;
Vargas-Vazquez, Arsenio ;
Aguilar-Salinas, Carlos A. .
GACETA MEDICA DE MEXICO, 2018, 154 :S50-S55
[9]   Visceral Adiposity Index A reliable indicator of visceral fat function associated with cardiometabolic risk [J].
Amato, Marco C. ;
Giordano, Carla ;
Galia, Massimo ;
Criscimanna, Angela ;
Vitabile, Salvatore ;
Midiri, Massimo ;
Galluzzo, Aldo .
DIABETES CARE, 2010, 33 (04) :920-922
[10]   EXPLORATION OF SIMPLE INSULIN SENSITIVITY MEASURES DERIVED FROM FREQUENTLY SAMPLED INTRAVENOUS GLUCOSE-TOLERANCE (FSIGT) TESTS - THE INSULIN-RESISTANCE ATHEROSCLEROSIS STUDY [J].
ANDERSON, RL ;
HAMMAN, RF ;
SAVAGE, PJ ;
SAAD, MF ;
LAWS, A ;
KADES, WW ;
SANDS, RE ;
CEFALU, W .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 142 (07) :724-732